| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/26/2001 | WO2001053291A1 Benzimidazole derivatives |
| 07/26/2001 | WO2001053290A1 Cell division inhibitors and process for producing the same |
| 07/26/2001 | WO2001053289A1 Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 07/26/2001 | WO2001053288A1 Novel piperidine compounds and drugs containing the same |
| 07/26/2001 | WO2001053285A1 Food product and process |
| 07/26/2001 | WO2001053282A1 Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 07/26/2001 | WO2001053280A1 Substituted phenylamidines medicaments containing said compounds and method for production thereof |
| 07/26/2001 | WO2001053279A1 Urea compounds as inhibitors for vla-4 |
| 07/26/2001 | WO2001053278A1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors |
| 07/26/2001 | WO2001053276A1 Dihydrofolate reductase inhibitors |
| 07/26/2001 | WO2001053274A1 Amide compounds for inhibiting protein kinases |
| 07/26/2001 | WO2001053273A1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 07/26/2001 | WO2001053272A1 Human chymase inhibitors |
| 07/26/2001 | WO2001053271A1 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 07/26/2001 | WO2001053268A2 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
| 07/26/2001 | WO2001053267A1 Compounds exhibiting thrombopoietin receptor agonism |
| 07/26/2001 | WO2001053266A1 Therapeutic morpholino-substituted compounds |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053262A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053261A1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 07/26/2001 | WO2001053260A1 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
| 07/26/2001 | WO2001053258A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 07/26/2001 | WO2001053257A2 Compounds having hypolipedemic and hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them |
| 07/26/2001 | WO2001053256A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same |
| 07/26/2001 | WO2001053255A1 Gamma-secretase inhibitors |
| 07/26/2001 | WO2001053254A1 Calcilytic compounds |
| 07/26/2001 | WO2001052904A2 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| 07/26/2001 | WO2001052903A1 Method for nucleic acid transfection of cells |
| 07/26/2001 | WO2001052902A1 Antisense modulation of inducible nitric oxide synthase expression |
| 07/26/2001 | WO2001052901A1 Drugs for gene therapy |
| 07/26/2001 | WO2001052897A2 Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitors |
| 07/26/2001 | WO2001052896A2 Compositions with enhanced oral bioavailability |
| 07/26/2001 | WO2001052895A1 Pharmaceutical compositions comprising terbinafine |
| 07/26/2001 | WO2001052893A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | WO2001052892A2 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | WO2001052891A1 Inhibitors for plasmodial invasion into erythrocytes |
| 07/26/2001 | WO2001052889A1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 07/26/2001 | WO2001052882A1 Combination of temozolomide and pegylated interferon-alpha for treating cancer |
| 07/26/2001 | WO2001052876A1 Ophthalmic compositions for treating ocular hypertension |
| 07/26/2001 | WO2001052874A2 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 07/26/2001 | WO2001052870A1 Treatment of congestive heart failure by pretreated autologous blood |
| 07/26/2001 | WO2001052868A1 Combinations for treating neoplasms |
| 07/26/2001 | WO2001052867A1 Use of pentosan polysulfate to treat certain conditions of the prostate |
| 07/26/2001 | WO2001052866A1 Dextrin containing compositions for prevention of adhesions |
| 07/26/2001 | WO2001052865A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
| 07/26/2001 | WO2001052863A1 Antisense modulation of mekk2 expression |
| 07/26/2001 | WO2001052862A1 Antisense modulation of glycogen synthase kinase 3 beta expression |
| 07/26/2001 | WO2001052861A1 Diagnosis and treatment of mental disorders |
| 07/26/2001 | WO2001052860A2 Method and composition for modulating an immune response |
| 07/26/2001 | WO2001052859A1 Pharmaceutical parenteral composition containing a biphosphonate |
| 07/26/2001 | WO2001052858A1 Tetracycline compounds for treatment of cryptosporidium parvum related disorders |
| 07/26/2001 | WO2001052857A1 Drospirenone for hormone replacement therapy |
| 07/26/2001 | WO2001052856A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 07/26/2001 | WO2001052855A2 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 07/26/2001 | WO2001052854A1 Nk1-receptor antagonists for treatment of restless legs syndrome |
| 07/26/2001 | WO2001052853A1 Anxiety method |
| 07/26/2001 | WO2001052852A1 Water soluble prodrugs of azole compounds |
| 07/26/2001 | WO2001052851A1 Methods for the treatment of substance abuse |
| 07/26/2001 | WO2001052850A1 Treatment of lymphomas, leukemias, breast carcinomas, astrocytomas, melanomas, leiomyomas, and related tumors |
| 07/26/2001 | WO2001052849A1 Remedies for diabetes |
| 07/26/2001 | WO2001052848A2 Functional coating of linezolid microcapsules for oral administration |
| 07/26/2001 | WO2001052847A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 07/26/2001 | WO2001052846A1 Gyrase inhibitors and uses thereof |
| 07/26/2001 | WO2001052845A1 Gyrase inhibitors and uses thereof |
| 07/26/2001 | WO2001052844A1 Brain, spinal and nerve injury treatment |
| 07/26/2001 | WO2001052843A1 β-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS |
| 07/26/2001 | WO2001052842A1 Compositions for the prevention of diaper dermatitis |
| 07/26/2001 | WO2001052841A1 Decursinol or derivative thereof as analgesic agent |
| 07/26/2001 | WO2001052840A1 Use of isoflavones and/or african plum extracts for preparing a composition designed to inhibit 5$g(a)-reductase activity, in pharmacology particularly in dermatology, in cosmetics and as food additive |
| 07/26/2001 | WO2001052839A1 Use of flavone 8-acetic acid in vascular and cardiovascular interventions and acute coronary syndromes |
| 07/26/2001 | WO2001052838A1 Purifying polyoxyethylated castor oils with activated charcoal and pharmaceutical formulations thereof |
| 07/26/2001 | WO2001052837A2 Use of at least a fatty ester for preparing a composition designed to inhibit 5-$g(a)-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive |
| 07/26/2001 | WO2001052836A1 Intravenous carnitine for the treatment of chronic uraemic patients undergoing periodical dialysis |
| 07/26/2001 | WO2001052835A2 Free radical scavengers for the treatment of premature birth |
| 07/26/2001 | WO2001052834A1 Remedies for hepatitis containing alanine and glycine |
| 07/26/2001 | WO2001052833A1 Compositions for delivery of a cortisol antagonist |
| 07/26/2001 | WO2001052832A1 Ocular growth and nicotinic antagonists |
| 07/26/2001 | WO2001052831A1 Use of ribose supplementation for increasing muscle mass and decreasing body fat in humans |
| 07/26/2001 | WO2001052830A2 METHODS TO TREAT α-1-ANTITRYPSIN DEFICIENCY |
| 07/26/2001 | WO2001052829A2 Statin-type bone growth stimulators |
| 07/26/2001 | WO2001052828A2 Glutamine prevention of delayed-onset irinotecan-induced diarrhea |
| 07/26/2001 | WO2001052827A1 Control of microbial populations in the gastrointestinal tract of animals |
| 07/26/2001 | WO2001052826A2 Novel podophyllotoxin compositions |
| 07/26/2001 | WO2001052825A2 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 07/26/2001 | WO2001052824A2 Use of particular compounds for prophylaxis and treatment of hepatitis c |
| 07/26/2001 | WO2001052821A1 Improved pharmaceutical formulations |
| 07/26/2001 | WO2001052818A1 Dry powder formulations of antihistamine for nasal administration |
| 07/26/2001 | WO2001052817A2 Cochleate formulations and their use for delivering biologically relevant molecules |
| 07/26/2001 | WO2001052816A2 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 07/26/2001 | WO2001052815A1 Multi-step drug dosage forms |
| 07/26/2001 | WO2001052814A1 Local drug delivery using photosensitizer-mediated and electromagnetic radiation-enhanced vascular permeability |
| 07/26/2001 | WO2001052813A1 Multi-spike release formulation for drug delivery |
| 07/26/2001 | WO2001052812A1 Diclofenamide suspension gel |
| 07/26/2001 | WO2001052805A1 Anti-microbial compositions comprising a salt of a transition metal chelator |
| 07/26/2001 | WO2001052745A1 Novel dyes |
| 07/26/2001 | WO2001052743A1 Tunable indocyanine dyes for biomedical applications |
| 07/26/2001 | WO2001052651A2 Particulate blends and compacted products formed therefrom, and the preparation thereof |
| 07/26/2001 | WO2001047807A8 Method for preparing ortho silicic acid, ortho silicic acid as obtained, and its use |
| 07/26/2001 | WO2001046180A8 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 07/26/2001 | WO2001022944A8 Oral controlled release formulations |